The expression level of KLK10 mRNA in ALL patients after one month and three months of receiving chemotherapy were decreased compared to their levels in normal blood samples (p < 0.0001 and p = 0.0175 respectively). This evidence concerns the gene KLK10 and acute lymphoblastic leukemia.